MILAN (AIMnews.it) - Kolinpharma is the fifth listing in 2018 on AIM, which brings the number of companies to 98 on the SMB list. "The focus on innovation and the great potential of the reference market gives us great confidence for the future and allows us to focus on projects aimed at strengthening scientific research, expanding the sales network and internationalisation", says 'AD of Kolinpharma Emanuele Lusenti. In the placement phase, the company, an Innovative SME that operates in the nutraceutical sector, has raised 3.1 million euros, the free float at the time of admission is 31.65% with a capitalisation of 10.2 million EUR.
Sign in to PMI Capital or ask for an invitation to display the listed companies documents and research hub papers, take part in the events and invest in the market consciously.
